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Abstract. 	Pregnancy	loss	during	the	late	embryonic	and	early	fetal	periods	influences	dairy	herd	economy.	The	objectives	of	
this	study	were	to	(1)	investigate	the	effects	of	a	single	or	double	GnRH	dose	administered	at	the	time	of	pregnancy	diagnosis	
(28–34	days	post-AI)	on	the	pregnancy	survival	of	cows	in	their	third	lactation	or	further	carrying	live	singletons	or	unilateral	
twins,	and	(2)	examine	the	impacts	of	GnRH	treatment	on	subsequent	twin	reduction	in	twin	pregnancies.	Cows	carrying	
singletons (n = 1,054) or unilateral twins (n = 379) were assigned at the time of pregnancy diagnosis to the following groups: 
control	(no	treatment),	GnRH	(100	μg	GnRH),	and	2GnRH	(200	μg	GnRH).	Pregnancy	loss	was	recorded	in	180	of	the	1,433	
cows	(12.6%)	at	58–64	days	post-AI.	Based	on	the	odds	ratios,	there	was	a	significant	(P	<	0.0001)	interaction	between	the	
treatment	group	and	twin	pregnancy.	This	interaction	implies	that	control	cows	carrying	twins	were	3.2	times	more	likely	to	
suffer	pregnancy	loss	than	the	other	cows,	whereas	the	GnRH	and	2GnRH	treatment	groups	cows	carrying	singletons	or	twins	
had	pregnancy	loss	rates	similar	to	the	control	cows	carrying	singletons.	Twin	reduction	was	observed	in	35	twin	pregnancies	
(9.2%).	Cows	in	the	GnRH	and	2	GnRH	groups	were	seven	times	more	likely	to	show	twin	reduction	than	control	cows.	
Our	results	indicate	that	GnRH	administered	at	the	time	of	pregnancy	diagnosis	had	no	beneficial	effects	in	cows	carrying	
singletons.	In	contrast,	for	twin	pregnancies,	the	treatment	increased	the	rate	of	pregnancy	survival	and	was	accompanied	by	
an	increase	in	the	twin	reduction	rate.
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Pregnancy loss during the late embryonic and early fetal period is an	important	factor	for	dairy	herd	economy	[1,	2].	Parity	(third	
lactation or more) has been related to pregnancy loss in dairy cows 
[3,	4];	however,	the	main	non-infectious	factor	that	compromises	
pregnancy	maintenance	during	the	first	trimester	of	gestation	is	
carrying	twins	[5,	6].	In	some	dairy	herds,	twin	pregnancy	rates	
can	be	18%	or	higher,	and	twins	are	much	more	common	in	older	
cows	[7].	Despite	the	reports	on	spontaneous	embryo	reduction	
rates	from	11.2	to	28.4%	occurring	around	28–40	days	of	gestation	
[8–10],	twin	pregnancy	losses	can	exceed	50%,	especially	during	
the	warm	period	of	the	year	[11,	12].	Thus,	the	risk	of	pregnancy	
loss	for	cows	carrying	twins	may	be	three	to	seven	times	higher	than	
that	for	cows	carrying	singletons.	In	addition,	losses	are	five	to	nine	
times higher for unilateral twins than for bilateral twins, whereas 
spontaneous	twin	reduction	mostly	occurs	in	bilateral	twins	[6,	8].
Studies	have	shown	that	GnRH	or	hCG	treatment	applied	at	the	
time	of	pregnancy	diagnosis	(i.e.,	28–40	days)	has	no	apparent	effect	
on	the	subsequent	pregnancy	loss	rate	in	cows	carrying	singletons	
[13]	or	other	pregnancy	types	[14,	15].	However,	it	has	been	estab-
lished	that	GnRH	treatment	in	cows	carrying	twins	favors	pregnancy	
maintenance	[6,	16].	In	a	previous	study,	it	was	found	that	GnRH	
treatment promoted twin reduction compared to progesterone-based 
treatment, but this study did not include untreated control cows 
[13].	It	remains	unclear	why	GnRH	administration	at	the	time	of	
pregnancy diagnosis does not reduce the losses in single pregnancies 
but	does	so	in	twin	pregnancies.	Increased	GnRH	doses	enhance	
pituitary	LH	release	[17];	therefore,	the	first	hypothesis	tested	in	this	
study	was	whether	a	double	dose	treatment	of	GnRH	would	reduce	
pregnancy	loss	rates	in	both	single	and	twin	pregnancies.	Our	second	
hypothesis was that twin reduction in unilateral twin pregnancies 
may	be	related	to	improved	pregnancy	maintenance.	Cows	in	their	
third lactation or further carrying unilateral twins or singletons are 
a good model to assess hormone treatments that could help sustain 
pregnancy.	Accordingly,	the	objectives	of	this	study	were	to	(1)	to	
examine	the	effects	of	the	recommended	dose	(100	μg)	or	a	double	
dose	(200	μg)	of	GnRH	(gonadorelin)	administered	at	the	time	of	
pregnancy	diagnosis	(28–34	days	post-AI)	on	pregnancy	survival	in	
cows in their third lactation or further and were carrying singletons 
or unilateral twins, and (2) examine the possible relationship between 
GnRH	treatment	and	subsequent	twin	reduction	in	twin	pregnancies.
Materials and Methods
Cattle, herd management, and pregnancy diagnosis
The	study	population	was	a	commercial	dairy	herd	of	2,120	
Holstein-Friesian	lactating	dairy	cows	in	northeastern	Spain.	During	
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the	study	period	(November	2014	to	April	2016),	the	mean	number	
of	lactating	cows	in	the	herd	was	2,120,	and	the	mean	annual	milk	
production	was	12,190	kg	per	cow.	An	early	postpartum,	or	“fresh	
cow”,	group	was	established	for	postpartum	daily	checks	and	nutrition	
controls	from	3	to	25	days	postpartum.	During	the	postpartum	daily	
checks,	the	following	puerperal	diseases	were	treated	until	they	were	
resolved	or	until	cows	were	culled:	signs	of	injury	to	the	genital	area	
(i.e.,	vaginal	or	recto-vulvar	lacerations),	metabolic	diseases,	such	as	
hypocalcemia	and	ketosis	(for	the	latter,	the	diagnosis	was	during	the	
first	or	second	week	postpartum),	retained	placenta	(fetal	membranes	
that were retained longer than 12 h after parturition), or puerperal 
metritis	(diagnosed	during	the	first	or	second	week	postpartum	in	
cows	without	placenta	retention).	Cows	were	milked	three	times	
daily	and	fed	complete	rations.	Only	healthy	cows	in	their	third	
lactation	or	further	with	no	signs	of	mastitis,	lameness,	or	digestive	
disorders	(28–34	to	58–64	days	post-AI)	were	included	in	the	study.	
This	strict	protocol	was	designed	to	minimize	the	variation	in	the	
general health state of the animals so that pregnancy loss could be 
attributed	to	the	factors	not	associated	with	these	clinical	conditions.	
Although estrus detection, using a pedometer system, started on 
day	14	postpartum,	the	voluntary	waiting	period	for	the	herd	was	
50	days.	All	cows	were	artificially	inseminated,	and	the	herd	was	
maintained	on	a	weekly	reproductive	health	program,	as	described	
in	a	previous	study	[18].	At	the	end	of	the	voluntary	waiting	period	
(40–46	days	postpartum),	the	reproductive	tract	of	each	animal	was	
examined	by	ultrasound	to	check	for	normal	uterine	involution	and	
ovarian	structures.	Reproductive	disorders	diagnosed	during	time,	
such	as	endometritis	or	ovarian	cysts,	were	treated	until	resolved.	
During	the	weekly	reproductive	visit,	open	cows	that	were	more	
than	60	days	in	milk,	that	had	no	estrous	signs	for	at	least	21	days,	
and	in	absence	of	a	corpus	luteum	received	a	five-day	progesterone-
based	synchronization	protocol	for	fixed-time	artificial	insemination	
(FTAI).	These	cows	were	treated	with	a	controlled	intravaginal	
progesterone-releasing	device	(CIDR;	Zoetis	Spain	SL,	Alcobendas,	
Madrid,	Spain)	that	contained	1.38	g	of	progesterone	and	GnRH	
(100	μg	gonadorelin	diacetate	tetrahydrate	IM;	Cystoreline,	CEVA	
Salud	Animal,	Barcelona,	Spain)	upon	the	insertion	of	the	CIDR.	
The	CIDR	was	left	in	place	for	5	days,	and	these	animals	were	also	
administered	cloprostenol	(500	μg	cloprostenol	IM;	Cyclix	bovino,	
Virbac	España	S.A.,	Barcelona,	Spain)	when	the	CIDR	was	removed.	
Twenty-four	and	36	h	later,	the	cows	received	a	second	cloprostenol	
dose	and	a	second	GnRH	dose,	respectively,	and	were	inseminated	
50–56	h	after	the	removal	of	the	CIDR	[18].	If	a	cow	had	a	corpus	
luteum that was estimated to be at least 15 mm in diameter (the 
mean of the maximum and minimum measurements), the cow was 
treated	with	cloprostenol.	The	cows	that	failed	to	show	signs	of	estrus	
during	the	5	days	following	treatment	received	the	FTAI	protocol.
Pregnancy was diagnosed by transrectal ultrasonography from 
28	to	34	days	post-AI	using	a	portable	B-mode	ultrasound	scanner	
that	was	equipped	with	a	5–10-	MHz	transducer	(E.I.	Medical	IBEX	
LITE;	E.I.	Medical	Imaging,	Loveland	CO,	USA).	Each	ovary	
was	scanned	in	several	planes	by	moving	the	transducer	along	its	
surface to identify luteal structures, and the number and location 
of	the	corpora	lutea	were	recorded.	Scanning	was	performed	along	
the	dorso/lateral	surface	of	each	uterine	horn.	The	presence	of	twins	
was	determined	by	an	observation	of	two	embryos	in	different	posi-
tions within one uterine horn using the two screen scan, when there 
were two embryos simultaneously present on the screen (unilateral 
twin pregnancy), or when one embryo was in each uterine horn 
(bilateral	twin	pregnancy).	The	viability	of	an	embryo/fetus	was	
confirmed	by	the	observation	of	heartbeat	during	all	examinations.	
Only	cows	carrying	single	or	unilateral	twins	with	live	embryos	at	
the	time	of	pregnancy	diagnosis	were	included	in	the	study.	Animals	
were excluded from the experiment if the following four conditions 
existed:	First,	cows	with	bilateral	twin	pregnancies	(n	=	245)	with	
twin	reduction	induced	by	amnion	rupture	[6]	were	excluded,	and	
this was routinely performed in all bilateral pregnancies for the 
herd.	Second,	cows	where	the	number	of	corpora	lutea	exceeded	
the number of embryos (422 cows carrying singletons and 9 cows 
carrying unilateral twins) were excluded, because an additional corpus 
luteum is as a strong factor that promotes pregnancy maintenance 
[19,	20].	Third,	cows	with	a	dead	co-twin	(n	=	64)	were	excluded,	
because the presence of a dead co-twin at the time of pregnancy 
diagnosis	is	highly	related	to	pregnancy	loss	[6].	Fourth,	cows	that	
had	a	previous	pregnancy	loss	during	the	same	lactation	period	(n	=	
128)	were	excluded.	Cows	were	included	only	once	in	the	experiment.
The	final	study	population	comprised	of	1,433	cows	carrying	
live	singletons	(n	=	1,054)	or	unilateral	twins	(n	=	379)	during	the	
experimental	period.	All	embryos	were	located	ipsilateral	to	their	
corresponding	corpora	lutea.
The	number	of	fetuses	was	revised	by	ultrasound	from	58	to	64	
days	post-AI.	Pregnancy	loss	was	recorded	when	this	exam	proved	
negative.	Twin	reduction	was	recorded	when	the	remnants	of	a	dead	
co-twin	were	observed	next	to	a	live	fetus	in	twin	pregnancies.	All	
gynecological exams and pregnancy diagnoses were performed by 
the	last	author	(FLG).
Experimental design
All	procedures	were	approved	by	the	Ethics	Committee	on	Animal	
Experimentation	of	the	University	of	Lleida	(license	numbers	
CEEA.06-01/12	and	CEEA.09-01/13).
Cows	carrying	live	singletons	(S)	or	unilateral	twins	(T)	at	the	
time	of	pregnancy	diagnosis	were	alternately	assigned	on	a	weekly	
rotational basis according to the chronological order of the gynecologic 
visits	to	the	groups.	The	three	groups	were	the	control	with	no	
treatment	(S:	n	=	349;	T:	n	=	122),	GnRH	with	a	treatment	of	one	
GnRH	dose	(S:	n	=	349;	T:	n	=	133),	and	2GnRH	with	a	treatment	
of	a	double	GnRH	dose	(S:	n	=	356;	T:	n	=	124).	Cows	in	the	GnRH	
group	were	treated	with	100	μg	gonadorelin	diacetate	tetrahydrate	IM	
(Cystoreline,	CEVA	Salud	Animal,	Barcelona,	Spain).	Cows	in	the	
2GnRH	group	received	200	μg	gonadorelin	diacetate	tetrahydrate	IM.
Data collection and statistical analysis
The	following	data	were	recorded	for	each	animal:	parturition	and	
AI dates, lactation number, insemination number, treatment (control 
vs.	GnRH	and	2GnRH),	milk	production	at	the	time	of	treatment	
(mean	production	during	the	three	days	before	the	positive	pregnancy	
diagnosis)	(low	producers	<	40	kg	vs.	high	producers	≥	40	kg),	days	
in	milk	at	AI	(DIM;	<	90	days	postpartum	vs.	≥	90	days	postpartum),	
semen-providing	bull,	conception	between	28	to	34	days	post-AI,	
presence of twins, and pregnancy loss or twin reduction between 
58	to	64	days	post-AI.	The	pregnancy	loss	rate	was	defined	as	the	
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number of cows with a pregnancy loss as a percentage of the total 
number	of	cows	in	each	group.	The	twin	reduction	rate	was	defined	
as the number of cows carrying twins that had twin reduction as a 
percentage	of	the	total	number	of	twin	pregnancies	in	each	group.	
The	insemination	dates	were	used	to	assess	the	effects	of	time	of	year	
(warm vs.	cool	period)	on	subsequent	reproductive	performance	of	
cows.	It	should	be	noted	that	in	our	geographical	region,	there	are	
only	two	clearly	differentiated	weather	periods,	which	are	the	warm	
period from May to September and the cool period from October 
to	April	[3,	21].
Overall	the	reproductive	performance	of	the	three	treatment	
groups	was	evaluated	using	a	chi-square	test	(percentages)	or	a	
Student’s t-test	(means	±	SD).	The	effect	of	the	treatment	group	
on	pregnancy	loss	and	the	twin	reduction	rate	were	analyzed	using	
a	logistic	regression	(logistic	procedure	of	PASW	Statistics	for	
Windows	Version	18.0,	SPSS	Inc.,	Chicago,	IL,	USA)	adjusting	
for	lactation,	days	in	milk,	milk	production,	insemination	number,	
and	time	of	year.	The	estimates	and	Wald	95%	limits	were	used	to	
calculate	the	odds	ratios	and	95%	confidence	intervals	(CI).	The	
explanatory	variables	and	the	interaction	were	evaluated	using	a	
backward	elimination	procedure,	and	the	variables	that	significantly	
affected	pregnancy	or	ovulation	rate	remained	in	the	model	[22].	
The	level	of	significance	was	set	at	P	<	0.05.	Values	are	expressed	
as	the	mean	±	the	standard	deviation	(SD).
Results
The	mean	milk	production	at	the	time	of	treatment,	days	in	milk	
at AI, number of lactations, and the number of inseminations were 
47.7	±	7.5	kg	(25–87	kg),	128.7	±	42.4	days	(51–291	days),	3.5	±	
0.7	(3–8	lactations),	and	2.7	±	1.7	(1–9	inseminations),	respectively	
(mean	±	SD,	range	in	parentheses).	Cows	were	inseminated	using	
semen	from	16	bulls.	Pregnancy	loss	was	recorded	in	180	cows	
(12.6%)	58–64	days	post-AI,	whereas	twin	reduction	was	observed	
in	35	twin	pregnancies	(9.2%).	The	independent	variables	recorded	
for	each	of	the	three	treatment	groups	and	the	effects	of	the	different	
treatments	on	pregnancy	loss	are	shown	in	Table	1.	Pregnancy	
loss	rate	showed	a	significant	increase	(P	<	0.001)	in	the	control	
group	(17.2%)	compared	to	that	in	the	GnRH	(12.4%)	and	2GnRH	
(12.3%)	groups.
Considering	the	presence	of	single	or	twin	pregnancy,	Table	2 
summarizes	the	pregnancy	loss	rate,	odds	ratios,	and	95%	CI.	The	
final	model	included	the	effect	of	the	warm	period	of	the	year	and	the	
interaction	between	type	of	pregnancy	and	treatment.	Lactation,	milk	
Table 1.	 Independent	variables	recorded	at	the	time	of	treatment,	and	the	effects	of	the	different	treatments	
on pregnancy loss (n = 1,433: 1,054 single pregnancies and 379 unilateral twin pregnancies)
Control Single	GnRH	dose Double	GnRH	dose
(n = 471) (n = 482) (n = 480)
Independent	variables	*
Lactation	number	(mean	±	SD) 3.5	±	0.7 3.6	±	0.8 3.5	±	0.7
AI	number	(mean	±	SD) 2.8	±	1.8 2.7	±	1.7 2.7	±	1.7
Milk	production	(≥	40	kg) 291	(61.8%) 292	(60.6%) 295	(61.5%)
Days	in	milk	(>	90	days) 271	(57.4%) 292	(60.6%) 290	(60.4%)
Pregnancies during the warm period 264	(56.1%) 254	(52.7%) 270	(56.3%)
Dependent	variable	**
Pregnancy loss 81	(17.2%)	a 60	(12.4%)	b 59	(12.3%)	b
*	No	significant	differences	were	detected	by	 the	Student’s	 t-test	 (means	±	SD)	or	 the	chi-square	 test	
(percentages).	**	Values	with	different	superscripts	within	rows	denote	significant	differences	detected	
by	the	chi-square	test	(P	<	0.001).
Table 2.	 Odds	ratios	for	pregnancy	loss	of	the	variables	included	in	the	final	logistic	regression	model	(n	=	1,433:	1,054	single	
pregnancies and 379 unilateral twin pregnancies)
Factor Class n %	losses Odds ratio 95%	confidence	
interval
P
Period of AI Cool 69/645 10.7 Reference
Warm 131/788 16.6 1.6 1.2–2.2 0.001
Twin	pregnancy	×	treatment S	×	C 43/349 12.3 Reference
S	×	GnRH 45/349 12.9 1.2 0.6–2.0 0.5
S	×	2GnRH 44/356 12.4 1.1 0.6–2.1 0.8
T	×	C 38/122 31.1 3.2 1.6–5.3 <	0.0001
T	×	GnRH 15/133 11.3 0.9 0.5–2.4 0.4
T	×	2GnRH 15/124 12.0 0.9 0.4–2.3 0.5
S:	single	pregnancies;	T:	twin	pregnancies;	C:	control	cows;	GnRH:	cows	that	received	a	single	GnRH	dose;	2GnRH:	cows	that	
received	a	double	GnRH	dose.	Hosmer	and	Lemeshow	goodness-of-fit	=	4.8;	P	=	0.91.	R2	Nagelkerke	=	0.12.
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production,	days	in	milk,	semen-providing	bull,	and	repeat	breeder	
syndrome	were	not	significant	and	were	not	included	in	the	final	
model.	The	likelihood	of	pregnancy	loss	was	1.6	times	higher	(P	=	
0.001)	during	the	warm	period	of	the	year	than	that	of	the	cool	period	
of	the	year.	There	was	a	significant	(P	<	0.0001)	interaction	between	
the treatment group and the type of pregnancy on the probability 
of	pregnancy	loss.	This	interaction	implies	that	a	lack	of	treatment	
may increase the pregnancy loss rate in cows with twin pregnancies 
by	3.2	times,	where	the	cows	in	the	GnRH	and	2GnRH	treatment	
groups that carried singletons or twins had similar pregnancy loss 
rates	to	that	of	the	control	cows	that	carried	singletons.
Twin	reduction	was	observed	in	35	of	the	379	(9.2%)	cows	that	
carried	unilateral	twins.	There	were	no	significant	effects	detected	
on	the	twin	reduction	rate	with	lactation,	milk	production,	days	in	
milk,	time	of	year,	semen-providing	bull,	or	repeat	breeder	syndrome,	
and	these	variables	were	not	included	in	the	final	model.	Based	on	
the	odds	ratios	(Table	3),	cows	in	the	GnRH	and	2GnRH	groups	
were	7	(P	=	0.007)	and	7.5	times	(P	=	0.002)	more	likely	to	show	
twin	reduction	than	the	control	cows,	respectively.	No	interactions	
were	found.	In	the	binary	logistic	regression	analysis	that	excluded	
the	control	cows,	no	differences	were	detected	between	the	two	
treatment	groups.
Discussion
Our study population was comprised of old cows (in their third 
lactation or further) carrying singletons or unilateral twins to examine 
the	possible	dose-dependent	effects	of	GnRH	treatment.	These	animals	
showed	a	higher	risk	of	pregnancy	loss	compared	to	younger	cows	
carrying	singletons	or	cows	carrying	bilateral	twins	[3,	6].	Furthermore,	
we excluded cows with an additional corpus luteum, since this 
promotes pregnancy maintenance, and cows with a dead co-twin at 
the	time	of	pregnancy	diagnosis,	since	this	has	a	detrimental	effect	on	
pregnancy	survival	[19,	20].	Under	these	conditions,	however,	there	
were	similar	impacts	observed	from	the	single	or	double	GnRH	dose	
for	the	single	and	twin	pregnancies.	Hence,	our	starting	hypothesis	
that	a	double	GnRH	dose	would	reduce	the	pregnancy	loss	rate	was	
not	supported.	The	GnRH	treatment	was	unable	to	mitigate	the	losses	
in cows with single pregnancies, which is in agreement with prior 
findings	[13,	14],	but,	irrespective	of	the	dose,	the	pregnancy	loss	
rate was drastically reduced in unilateral twin pregnancies, which 
also	reinforces	previous	results	[6].	It	is	likely	that	the	amount	of	
gonadotropins	released	in	response	to	a	single	GnRH	dose	reaches	
an	arbitrary	level,	or	a	threshold,	that	triggers	a	sequence	of	events	
that	favors	pregnancy	for	cows	that	are	carrying	twins.	To	this	end,	
a	double	GnRH	dose	has	similar	consequences	once	the	threshold	
concentration	of	gonadotropins	has	been	reached.
The	findings	of	this	study	support	our	second	hypothesis	where	
there	would	be	an	expected	higher	rate	of	pregnancy	survival	for	
treated twin pregnancies that were accompanied by an increase 
in	twin	reduction	rate.	We	were	able	to	effectively	link	the	GnRH	
treatment to twin reduction in cows bearing unilateral twins, such 
that	treated	cows	were	7	(GnRH)	and	7.5	times	(2GnRH)	more	likely	
to	show	twin	reduction	than	control	cows.	This	link	likely	explains	a	
similar	percentage	of	pregnancy	loss	in	the	GnRH-treated	cows	with	
unilateral	twin	pregnancies	(11.3–12%)	and	the	untreated	control	
cows	carrying	singletons	(12.3%)	when	compared	to	high	losses	in	
the	control	twin	pregnancies	(31.1%).	In	other	words,	most	losses	
in the unilateral twin pregnancies may be related to a process of 
twin	reduction	in	the	control	cows.	Thus,	a	GnRH	treatment	does	
not	induce	twin	reduction	but	favors	the	maintenance	of	pregnancy	
when	one	of	the	twins	dies.	The	question	that	arises	is	how	the	GnRH	
treatment is able to sustain pregnancy in cows that undergo twin 
reduction.	The	reduction	of	twins	involves	the	gradual	dissolution	
of	a	single	conceptus	without	compromising	the	viability	of	its	
co-twin	[8,	10].	This	event	is	likely	accompanied	by	a	local	release	
of	cytokines	and	prostaglandins	from	the	uterine	tissue,	and	the	
GnRH,	presumably,	has	an	indirect	antiluteolytic	effect.	Depending	
on	the	follicular	status	at	the	time	of	pregnancy	diagnosis,	GnRH	
will	advance	follicular	atresia,	luteinization,	or	ovulation	followed	
by	luteinization	that	results	in	reduced	estradiol-17β	production	[23];	
this	could	disrupt	the	estradiol	control	of	the	uterus	leading	to	PGF2α 
release	[23,	24].	Thus,	a	reduction	in	estradiol	at	this	time	might	
inhibit luteolytic mechanisms, which may allow some pregnancies 
with	embryo	reduction	to	continue.	A	previous	study	that	reinforces	
this	idea	showed	that	an	anti-prostaglandin	treatment	with	flunixin	
meglumine	and	GnRH	administered	immediately	after	induced	twin	
reduction	favors	pregnancy	maintenance	[6].	Moreover,	the	presence	
of	two	corpora	lutea	should	further	benefit	pregnancy	maintenance	
of	a	single	embryo	with	its	corresponding	corpus	luteum.	More	
studies	that	include	information	about	follicle	activity,	number	of	
corpora lutea, plasma concentrations of progesterone, estradiol, 
and pregnancy associated glycoproteins might help identify the 
mechanism	that	inhibits	luteolysis.
Most cases of single embryo mortality in twins occurs around 
28–40	days	of	gestation	and	rarely	after	day	60	[8–10].	This	has	
important	practical	implications	for	the	fate	of	a	pregnancy	with	live	
twins	on	day	60,	in	which	there	will	be	twin	delivery	or	abortion.	
Table 3.	 Odds	ratios	for	twin	reduction	of	the	variables	included	in	the	final	logistic	regression	model	for	the	
twin pregnancies (n = 379)
Factor Class n %	twin	reduction Odds ratio
95%	confidence	
interval
P
Treatment C 2/122 1.6 Reference
GnRH 15/133 11.3 7.0 1.5–25.0 0.007
2GnRH 18/124 14.5 7.5 1.8–28.2 0.002
C:	control	cows;	GnRH:	cows	that	received	a	single	GnRH	dose;	2GnRH:	cows	that	received	a	double	GnRH	
dose.	Hosmer	and	Lemeshow	goodness-of-fit	=	4.2;	P	=	0.92.	R2	Nagelkerke	=	0.10.
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Accordingly,	the	assessment	of	live	twins	or	twin	reduction	at	this	
time	point	in	GnRH-treated	cows	or	in	cows	subjected	to	induced	
twin reduction should be a main component of herd management 
policy.	Thus,	for	non-aborting	cows	carrying	twins,	the	drying	period	
can	be	advanced	by	several	days,	and	additional	care	at	parturition	
can	help	increase	the	risk	of	survival	of	the	twin	calves.	In	contrast,	
cows	showing	twin	reduction	will	remain	pregnant	with	a	singleton.	
Thus,	increasing	the	twin	reduction	rate	through	a	GnRH	treatment	
will	reduce	pregnancy	losses	in	twin	pregnancies	and	will	offer	a	
way	to	lower	twin	birth	rates	in	dairy	herds.
In	conclusion,	our	first	hypothesis	that	a	double	GnRH	dose	would	
reduce	the	pregnancy	loss	rate	was	denied.	A	double	GnRH	dose	
administered	at	the	time	of	pregnancy	diagnosis	did	not	have	better	
effects	than	a	single	GnRH	dose	on	the	subsequent	twin	reduction	
rate	or	the	pregnancy	maintenance	rate.	Our	findings	indicate	that	
treatment	with	GnRH	at	the	time	of	pregnancy	diagnosis	has	no	
impact	on	the	course	of	the	pregnancy	in	cows	carrying	singletons.	
In contrast, in twin pregnancies this treatment increased the rate of 
twin	reduction	and	is	linked	to	a	substantially	reduced	likelihood	
of	pregnancy	loss.
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